approval · primary record
ECULIZUMAB
FDA · BLA · 2026-10-21
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-10-21 |
| Brand | SOLIRIS |
| Sponsor | ALEXION PHARM |
| Route | IV (INFUSION) |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-29T08:50:03.816Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ECULIZUMAB:2026-10-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Eculizumab · compound